Sale of around 1 million flavoured e-cigarettes banned by USFDA
Washington: The US Food and Drug Administration (FDA) has rejected more than 946,000 flavoured electronic nicotine delivery systems (ENDS) products, such as e-cigarettes and e-liquids, prohibiting them from being marketed or sold due to lack of sufficient evidence on health benefits.
The decision comes after a year-long review of millions of e-cigarette-related products by the global health body.
According to the FDA, flavoured tobacco products are very appealing to young people, with over 80 per cent of e-cigarette users aged 12 through 17 using them. Therefore, it is imperative to assess the potential impact of its use.
"We've made significant progress in the months since, working diligently to better understand these products and, as of today, taking action on about 93 per cent of the total timely-submitted applications," Janet Woodcock, MD, Acting Commissioner of Food and Drugs -- FDA, said in a statement on Thursday.
"This includes issuing Marketing Denial Orders (MDO) for more than 946,000 flavoured ENDS products because their applications lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the public health threat posed by the well-documented, alarming levels of youth use of such products," she added.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.